Epilepsy prediction models for children and adolescents: a systematic review and meta-analysis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Predictive models for childhood epilepsy show moderate accuracy, with clinical features and EEG outperforming MRI. Most studies have high bias and lack validation, highlighting the need for improved methodologies and external validation.
Area Of Science
- Pediatric Neurology
- Medical Informatics
Background
- Childhood epilepsy negatively impacts cognitive development and quality of life.
- Early risk identification is crucial for improving outcomes in pediatric epilepsy.
- Existing predictive models for pediatric epilepsy have shown inconsistent results, necessitating a comprehensive evaluation.
Purpose Of The Study
- To systematically review and integrate findings on the accuracy and effectiveness of epilepsy prediction models in children and adolescents.
- To evaluate the risk of bias and applicability of current epilepsy prediction models.
- To guide future research and inform clinical strategies for pediatric epilepsy.
Main Methods
- A comprehensive search of multiple databases (PubMed, Embase, CINAHL, Web of Science, etc.) was conducted.
- The Prediction Model Risk of Bias Assessment Tool was employed to assess study quality.
- Random-effects meta-analysis was used to pool the area under the curve (AUC) for model performance.
Main Results
- Twenty-seven studies were included, with 25 identified as high risk of bias.
- Pooled AUC for training models was 0.794, and for validation models was 0.726.
- Models combining clinical features and EEG demonstrated superior performance over those including MRI; non-machine learning models outperformed machine learning models.
Conclusions
- Current epilepsy prediction models for children and adolescents exhibit significant limitations, including high risk of bias and inadequate validation.
- Models utilizing clinical features and EEG warrant further investigation.
- Standardized methodologies for predictor selection and robust external validation are essential for improving the clinical utility of these models.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Focal aware seizures: In these seizures, the person remains conscious...
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...